Flunarizine in Migraine Prophylaxis: An Indian Trial
Version of Record online: 20 MAY 2005
Headache: The Journal of Head and Face Pain
Volume 31, Issue 9, pages 613–615, October 1991
How to Cite
Thomas, M., Behari, M. and Ahuja, G. (1991), Flunarizine in Migraine Prophylaxis: An Indian Trial. Headache: The Journal of Head and Face Pain, 31: 613–615. doi: 10.1111/j.1526-4610.1991.hed3109613.x
- Issue online: 20 MAY 2005
- Version of Record online: 20 MAY 2005
- Accepted for Publication: August 22, 1991.
- Cited By
Flunarizine, a calcium channel blocker is considered useful in migraine prophylaxis. We report the first Indian trial with thisdrug. Fifteen patients with migraine were studied in a 6 months double-blind, placebo-controlled crossover trial. Flunarizinewas superior to placebo in reducing the severity and duration of the individual attacks though there was no statisticallysignificant effect on frequency of migraine attacks. The side effects most frequently caused by flunarizine were weight gainand daytime sleepiness.